Notably, acute encephalitis mediated by anti‐myelin oligodendrocyte glycoprotein (MOG) antibodies is a common neurological demyelinating disease in clinical practice, with 21.3% of patients experiencing seizures [14]. This evidence concerns the gene MOG and encephalitis.